Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,710 public trials 183 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions: Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations: Ghent University Hospital Ghent, Belgium

Hopital Robert Debre Paris, France

Armand Trousseau Hospital Paris, France

Centre Hospitalier Universitaire de Poitiers Poitiers, France

View all 23 locations

View Trial Details

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

NCT04504526

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT06810778

Conditions: Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
Locations: David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States

View Trial Details

Recruiting

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

NCT04968834

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Connecticut Children's Medical Center Hartford, Connecticut, United States

Maine Medical Center Portland, Maine, United States

Boston Children's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

NCT06469307

Conditions: Blood Cancer, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

NCT01515527

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

NCT06580002

Conditions: Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
Locations: Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States

View Trial Details

Recruiting

Pre-malignant States to Hematologic Malignancies in Firefighters

NCT06870760

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Clonal Hematopoiesis of Indeterminate Potential, +20 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

View Trial Details

Recruiting

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

NCT03555851

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

View Trial Details

Recruiting

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

NCT07464951

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions